Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, discusses the genetic risk (or lack thereof) for lung cancer.

Dr. Nathan Pennell, Cleveland Clinic, describes other options for treatment of acquired resistance, including chemotherapy, ablation with SBRT and a combination of Gilotrif and Erbitux.

Dr. Jack West, Swedish Cancer Institute, reviews trial evidence for the efficacy of rociletinib and osimertinib for EGFR acquired resistance not driven by a T790M mutation.

Dr. Nathan Pennell, Cleveland Clinic, discusses the concept of acquired resistance and new agents designed to address it, including Rociletinib and Merelitinib.

For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library. In this video translation, Dr. Li discusses evolving standards for molecular testing in advanced NSCLC. We would like to

We are pleased to offer more additions to our Lung Cancer Video Library for our Spanish speaking community. Para conocer las adiciones más recientes a nuestra Biblioteca de videos sobre cáncer de pulmón, producida en español para nuestra comunidad latina, el Dr. Luis E. Raez nos brinda la

We are pleased to offer more additions to our Lung Cancer Video Library for our Spanish speaking community. Translating Molecular Oncology Results into Targeted Therapy Treatment For the newest additions to our Lung Cancer Video Library, produced in Spanish for our Latino Community, Dr. Luis E. Raez

We are pleased to offer more additions to our Lung Cancer Video Library for our Spanish speaking community. Para conocer las adiciones más recientes a nuestra Biblioteca de videos sobre cáncer de pulmón, producida en español para nuestra comunidad latina, el Dr. Luis E. Raez nos brinda la

For this new addition to the GRACE Lung Cancer Video Library, Dr. Sandip Patel joins GRACE to discuss current updates in non small cell lung cancer. In this video, Dr. Patel discusses updated information on emerging molecular targets in nsclc - EGFR Exon 20. To join the conversation, visit https:/

For this new addition to the GRACE Lung Cancer Video Library, Dr. Stephen Liu joins GRACE to discuss current updates in small cell lung cancer. In this video, Dr. Liu discusses updated information on immunotherapy for small cell lung cancer. To join the conversation, visit https://cancergrace.org

For this new addition to the GRACE Lung Cancer Video Library, Dr. Charu Aggarwal joins GRACE to discuss current updates in non small cell lung cancer. In this video, Dr. Aggarwal discusses updated information on the utility of liquid biopsies. To join the conversation, visit https://cancergrace.org

For this new addition to the GRACE Lung Cancer Video Library, Dr. Taofeek Owonikoko joins GRACE to discuss current updates in small cell lung cancer. In this video, Dr. Owonikoko discusses updated information on treatment options for relapsed sclc. To join the conversation, visit https://cancergrace

Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, describes the types of situations in which local therapy is appropriate for treating limited acquired resistance.

Dr. David Harpole, Duke University Medical Center, describes how he assists patients with the surgical decision-making process.

Dr. Jared Weiss, Vice President of GRACE and Associate Professor at UNC-Chapel Hill in Clinical Research, and the Thoracic Oncology Program at UNC Lineberger, discusses First Line EGFR-Based Therapy For Advanced Squamous Non-Small Cell Lung Cancer (NSCLC).